Cargando…
MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin
Background: The presence of glioma stem cells (GSCs) is thought to be a key factor responsible for development of the incurable glioblastoma multiforme (GBM). GSCs are often displayed during chemotherapy resistance, except for demethoxycurcumin (DMC), a component of curcumin, which has been previous...
Autores principales: | Qian, Chunfa, Wang, Bin, Zou, Yuanjie, Zhang, Yansong, Hu, Xinhua, Sun, Wenbo, Xiao, Hong, Liu, Hongyi, Shi, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664422/ https://www.ncbi.nlm.nih.gov/pubmed/31440081 http://dx.doi.org/10.2147/CMAR.S210076 |
Ejemplares similares
-
Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas
por: Shi, Lei, et al.
Publicado: (2020) -
ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin
por: Chen, Long, et al.
Publicado: (2017) -
MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
por: Zhao, Chengbin, et al.
Publicado: (2020) -
Effects of demethoxycurcumin on the viability and apoptosis of skin cancer cells
por: Wu, Yaoqun, et al.
Publicado: (2017) -
Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice In Vivo
por: Huang, Yi-Ping, et al.
Publicado: (2021)